Literature DB >> 16434004

[C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure].

Lyankis López1, Kaduo Arai, Esther Giménez, Mariela Jiménez, Carmine Pascuzo, Claudina Rodríguez-Bonfante, Rafael Bonfante-Cabarcas.   

Abstract

INTRODUCTION AND
OBJECTIVES: Chagas disease is the most common cause of myocarditis in Latin America, including Venezuela. Some 25% of patients progress to chronic chagasic cardiomyopathy, which is characterized by heart failure and arrhythmias. The serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) have prognostic value in non-chagasic cardiopathy. The goal of this study was to investigate the relationship between the serum levels of CRP and IL-6 and the developmental stage of Chagas disease. PATIENTS AND
METHOD: The study included 64 Chagas disease patients (34 female and 30 male; age 62.2 [1.7] years) and 20 healthy individuals (10 of each sex; age 50.4 [2.7] years). Clinical investigations included echocardiography and measurement of CRP and IL-6 serum levels using ELISAs. Chagas disease patients were graded according to Carrasco et al 1994 classification. Patients with ischemic cardiopathy, liver disease, autoimmune disease, a systemic inflammatory condition, immunosuppression, cancer, pericarditis, or endocarditis were excluded.
RESULTS: Multiple regression analysis demonstrated an association between Chagas disease developmental stage and the serum IL-6 level. The serum CRP level increased during only the most advanced phase of the disease. In addition, a high left ventricular mass index was associated with a high IL-6 level and male sex.
CONCLUSIONS: IL-6 and CRP serum levels could be of prognostic value in assessing Chagas disease progression because there are significant correlations between elevated levels and the deterioration of cardiac function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434004

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  20 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  Comparison between the collagen intensity and mast cell density in the lingual muscles and myocardium of autopsied chronic chagasic and nonchagasic patients.

Authors:  José A Roldão; Marcela Beghini; Luciana S Ramalho; Carla Souza Porto; Denise B R Rodrigues; Vicente P A Teixeira; Sanívia A de Lima Pereira
Journal:  Parasitol Res       Date:  2012-03-13       Impact factor: 2.289

3.  Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor.

Authors:  Joost H van den Berg; Raquel Gomez-Eerland; Bart van de Wiel; Lenie Hulshoff; Daan van den Broek; Adriaan Bins; Hanno L Tan; Jane V Harper; Namir J Hassan; Bent K Jakobsen; Annelies Jorritsma; Christian U Blank; Ton N M Schumacher; John B A G Haanen
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

Review 4.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

5.  Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.

Authors:  Eliziária C Santos; Rômulo D Novaes; Marli C Cupertino; Daniel S S Bastos; Raphael C Klein; Eduardo A M Silva; Juliana L R Fietto; André Talvani; Maria T Bahia; Leandro L Oliveira
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

6.  Trypanosoma cruzi infection induces the expression of CD40 in murine cardiomyocytes favoring CD40 ligation-dependent production of cardiopathogenic IL-6.

Authors:  Mariela Alejandra Moreno Ayala; Agustina Casasco; Mariela González; Miriam Postan; Ricardo Santiago Corral; Patricia Beatriz Petray
Journal:  Parasitol Res       Date:  2015-11-03       Impact factor: 2.289

7.  Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).

Authors:  Cristina Poveda; Manuel Fresno; Núria Gironès; Olindo A Martins-Filho; Juan David Ramírez; Julien Santi-Rocca; José A Marin-Neto; Carlos A Morillo; Fernando Rosas; Felipe Guhl
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 8.  Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?

Authors:  Alejandro Diaz-Hernandez; Maria Cristina Gonzalez-Vazquez; Minerva Arce-Fonseca; Olivia Rodriguez-Morales; Maria Lilia Cedilllo-Ramirez; Alejandro Carabarin-Lima
Journal:  Biology (Basel)       Date:  2021-05-06

9.  ADENOSINE DEAMINASE ACTIVITY AND SERUM C-REACTIVE PROTEIN AS PROGNOSTIC MARKERS OF CHAGAS DISEASE SEVERITY.

Authors:  Iván Darío Bravo-Tobar; Carlota Nello-Pérez; Alí Fernández; Nora Mogollón; Mary Carmen Pérez; Juan Verde; Juan Luis Concepción; Claudina Rodriguez-Bonfante; Rafael Bonfante-Cabarcas
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

10.  Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.

Authors:  Sonia Santeliz; Peter Caicedo; Elidiosmar Giraldo; Carmen Alvarez; María-Daniela Yustiz; Claudina Rodríguez-Bonfante; Romina Bonfante-Rodríguez; Rafael Bonfante-Cabarcas
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-09       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.